Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 97Leukemia 72Leukemia, Myeloid, Acute 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia, Lymphocytic, Chronic, B-Cell 52Lymphoma 48Myeloproliferative Disorders 47Lymphoma, Non-Hodgkin 46Leukemia, Myeloid, Chronic-Phase 44Hodgkin Disease 44Multiple Myeloma 43Leukemia, Myeloid, Accelerated Phase 41Lymphoma, Follicular 39Lymphoma, Mantle-Cell 38Lymphoma, B-Cell, Marginal Zone 37Burkitt Lymphoma 37Lymphoma, Large B-Cell, Diffuse 36Congenital Abnormalities 34Neoplasms, Plasma Cell 33Lymphoma, Large-Cell, Immunoblastic 32Blast Crisis 31Leukemia, Myelomonocytic, Chronic 30Primary Myelofibrosis 29Anemia, Refractory, with Excess of Blasts 28Dendritic Cell Sarcoma, Interdigitating 27Myelodysplastic-Myeloproliferative Diseases 26Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Recurrence 23Graft vs Host Disease 23

Interventions

venetoclax 1thymoglobulin 1tagraxofusp 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Rituximab 1Mycophenolic Acid 1Melphalan 1Clofarabine 1Busulfan 1Bone Marrow Transplantation 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Antilymphocyte Serum × Myeloid × Clear all
NCT01471067 2017-04-28

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
33 enrolled
LymphoidMyeloidOther hematologic neoplasm

Pathologic Complete Response, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Philadelphia Chromosome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡